Omega Healthcare Investors Q3 2026 net income falls 53% year over year to $86.82 million

OHI•2026-11-03

Omega Healthcare Investors reported third-quarter 2026 net income of $86.82 million, down 53% year over year, while adjusted funds from operations rose 8% to $262.09 million. It raised its 2026 adjusted funds from operations outlook to $3.28–$3.30 per diluted share.

Omega Healthcare Investors Q3 2026 net income falls 53% year over year to $86.82 million

1. Quarterly results

2. Outlook and loan

Related News

Crescent Biopharma grants employee options to buy 11,775 shares

Xilio Therapeutics to present at Stifel Healthcare Conference

COP31 will show up the folly of cleantech tariffs

Specialty chemicals supplier Innospec's Q3 revenue slightly misses estimates

Limbach Q3 net income rises 8% to $9.45 million; revenue climbs 25% to $230.46 million